175 related articles for article (PubMed ID: 38638439)
1. Bruton's tyrosine kinase inhibition limits endotoxic shock by suppressing IL-6 production by marginal zone B cells in mice.
Kawata K; Hatano S; Baba A; Imabayashi K; Baba Y
Front Immunol; 2024; 15():1388947. PubMed ID: 38638439
[TBL] [Abstract][Full Text] [Related]
2. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
Front Immunol; 2019; 10():2129. PubMed ID: 31552054
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
[TBL] [Abstract][Full Text] [Related]
4. X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure.
O'Riordan CE; Purvis GSD; Collotta D; Krieg N; Wissuwa B; Sheikh MH; Ferreira Alves G; Mohammad S; Callender LA; Coldewey SM; Collino M; Greaves DR; Thiemermann C
Front Immunol; 2020; 11():581758. PubMed ID: 33162995
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage.
Shaker ME; Gomaa HAM; Alharbi KS; Al-Sanea MM; El-Mesery ME; Hazem SH
Biomed Pharmacother; 2020 Nov; 131():110736. PubMed ID: 33152913
[TBL] [Abstract][Full Text] [Related]
6. Acalabrutinib, A Second-Generation Bruton's Tyrosine Kinase Inhibitor.
Kriegsmann K; Kriegsmann M; Witzens-Harig M
Recent Results Cancer Res; 2018; 212():285-294. PubMed ID: 30069636
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
8. CD38-mediated Inhibition of Bruton's Tyrosine Kinase in Macrophages Prevents Endotoxemic Lung Injury.
Farahany J; Tsukasaki Y; Mukhopadhyay A; Mittal M; Nepal S; Tiruppathi C; Malik AB
Am J Respir Cell Mol Biol; 2022 Feb; 66(2):183-195. PubMed ID: 34706199
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
10. Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia.
de Porto AP; Liu Z; de Beer R; Florquin S; Roelofs JJTH; de Boer OJ; den Haan JMM; Hendriks RW; van 't Veer C; van der Poll T; de Vos AF
Front Immunol; 2021; 12():723967. PubMed ID: 34552589
[TBL] [Abstract][Full Text] [Related]
11. Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies.
da Cunha-Bang C; Niemann CU
Drugs; 2018 Nov; 78(16):1653-1663. PubMed ID: 30390220
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.
Jefferies CA; Doyle S; Brunner C; Dunne A; Brint E; Wietek C; Walch E; Wirth T; O'Neill LA
J Biol Chem; 2003 Jul; 278(28):26258-64. PubMed ID: 12724322
[TBL] [Abstract][Full Text] [Related]
13. Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fcα/μR-coupled TLR4 signalling.
Honda S; Sato K; Totsuka N; Fujiyama S; Fujimoto M; Miyake K; Nakahashi-Oda C; Tahara-Hanaoka S; Shibuya K; Shibuya A
Nat Commun; 2016 May; 7():11498. PubMed ID: 27146354
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
Schmidt NW; Thieu VT; Mann BA; Ahyi AN; Kaplan MH
J Immunol; 2006 Nov; 177(10):7203-10. PubMed ID: 17082638
[TBL] [Abstract][Full Text] [Related]
15. Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr
Hemme E; Biskop D; Depuydt MAC; Smit V; Delfos L; Bernabé Kleijn MNA; Foks AC; Kuiper J; Bot I
Vascul Pharmacol; 2023 Jun; 150():107172. PubMed ID: 37075932
[TBL] [Abstract][Full Text] [Related]
16. Distinct Roles for Bruton's Tyrosine Kinase in B Cell Immune Synapse Formation.
Roman-Garcia S; Merino-Cortes SV; Gardeta SR; de Bruijn MJW; Hendriks RW; Carrasco YR
Front Immunol; 2018; 9():2027. PubMed ID: 30237801
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.
Patel NM; Oliveira FRMB; Ramos HP; Aimaretti E; Alves GF; Coldewey SM; Collino M; Sordi R; Thiemermann C
Ann Surg; 2023 Mar; 277(3):e624-e633. PubMed ID: 35129479
[TBL] [Abstract][Full Text] [Related]
18. Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
Benner B; Carson WE
J Hematol Oncol; 2021 Jan; 14(1):15. PubMed ID: 33441177
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly expressed Bruton's tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells.
Pikatan NW; Liu YL; Bamodu OA; Hsiao M; Hsu WM; Haryana SM; Sutaryo ; Chao TY; Yeh CT
Cell Oncol (Dordr); 2020 Dec; 43(6):1067-1084. PubMed ID: 32705581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
